Find out how to deal online from £1.50 in a SIPP, ISA or Dealing account.
Jump to:

Immunodiagnostic Systems Holdings Fundamentals

Company Name Immunodiagnostic System Last Updated 22 Oct 2019
Industry Health Care Sector Medical Equipment
Shares in Issue (m) 28.78 Market Cap (£m) 77.72
PE Ratio 100.00 Div per Share (p) 0.70
Div Yield 0.26 Div Cover 3.86
EPS 2.70 EPS Growth (%) -35.71
PEG -2.80 DPS Growth (%) -58.82
Debt Ratio 5.63 Debt Equity Ratio 0.31
Net Gearing -25.94 Gross Gearing 16.11
Asset Equity Ratio 1.19 Cash Equity Ratio 50.11
Quick Ratio 5.43 Current Ratio 6.50
Price To Book Value 1.41 ROCE 1.43

Immunodiagnostic Systems Holdings Dividends

Type Ex-Date Pay Date Currency Net Dividend Year Total
H2 Dividend 18 Jul 2019 15 Aug 2019 GBX 0.70 0.70
H2 Dividend 19 Jul 2018 17 Aug 2018 GBX 1.70 1.70
H2 Dividend 20 Jul 2017 18 Aug 2017 GBX 4.00 4.00
H2 Dividend 21 Jul 2016 19 Aug 2016 GBX 1.20 1.20
H2 Dividend 23 Jul 2015 21 Aug 2015 GBX 3.00 3.00

Immunodiagnostic Systems Holdings Company Financials

Assets (£m) 2019 2018 2017
Tangible Assets 7 7 9
Intangible Assets 11 11 10
Investments 0 1 1
Total Fixed Assets 18 19 20
Stocks 8 8 8
Debtors 9 8 8
Cash & Equivalents 28 29 32
Other Assets 3 3 2
Total Assets 66 68 69
Liabilities (£m) 2019 2018 2017
Creditors within 1 year 7 7 8
Creditors after 1 year 3 3 4
Other Liabilities 0 0 0
Total Liabilities 11 11 12
Net assets 55 57 57
Equity (£m) 2019 2018 2017
Called up share capital 1 1 1
Share Premium 32 32 32
Profit / Loss 1 1 1
Other Equity 5 5 5
Preference & Minorities 0 0 0
Total Capital Employed 55 57 57
Ratios 2019 2018 2017
Debt Ratio 5.63 5.65 6.25
Debt-to-Equity 0.31 0.32 0.32
Net Gearing -25.94 -26.45 -28.36
Gross Gearing 16.11 15.80 17.46
Assets / Equity 1.19 1.19 1.21
Cash / Equity 50.11 50.17 55.52
EPS 2.70 4.20 10.20
Cash Flow (£m) 2019 2018 2017
Cash from operating activities 6 3 8
Cashflow before financing 1 -1 5
Increase in Cash -1 -1 4
Income (£m) 2019 2018 2017
Turnover 39 38 40
Cost of sales 22 20 17
Gross Profit 17 18 23
Operating Profit 0 1 2
Pre-Tax profit 1 1 1
Profit / Loss for the year 1 1 1

Immunodiagnostic Systems Holdings Company Background

Sector Medical Equipment
Activities Immunodiagnostic Systems Holdings plc (IDS) is a specialist in-vitro diagnostic solution provider to the clinical laboratory market and producer of manual and automated diagnostic testing kits and instruments for the clinical market.
Latest Interim Date 23 Nov 2018
Latest Fiscal Year End Date 19 Jun 2019

Immunodiagnostic Systems Holdings Directors

Appointed Director Position
31 Oct 2017 Jaap Stuut Chief Executive Officer
04 Jan 2016 Paul James Martin Chief Financial Officer
25 Nov 2014 Dr Burkhard Wittek Non-Executive Chairman
15 Jun 2015 Peter John Williamson Non-Executive Director
01 Nov 2015 Klaus Peter Kaspar Non-Executive Director

Immunodiagnostic Systems Holdings Contact Details

Company Name Immunodiagnostic System
Company Address 10 Didcot Way, Boldon Business Park, Boldon, Tyne & Wear NE35 9PD.
Company Telephone +44 (0)191 519 0660
Company Website http://www.idsplc.com/

Immunodiagnostic Systems Holdings Advisors

Auditor Name Baker Tilly
Auditor Address 1 St James Gate, Newcastle upon Tyne NE1 4AD.
Auditor Website http://www.bakertilly.co.uk/
Auditor Telephone +44 (0)1483 307 000
Registrar Name Computershare Investor Service
Registrar Address The Pavillions, Bridgwater Road, Bristol BS99 1XZ.
Registrar Website http://www-uk.computershare.com/
Registrar Telephone 0870 702 0010
Broker Name N+1 Singer
Broker Address One Bartholomew Lane, London EC2N 2AX.
Broker Website http://www.n1singer.com/
Broker Telephone +44 (0)20 7496 3000
Adviser Name N+1 Singer
Adviser Address One Bartholomew Lane, London EC2N 2AX.
Adviser Website http://www.n1singer.com/
Adviser Telephone +44 (0)20 7496 3000
Solicitor Name Watson Burton
Solicitor Address 1 St James' Gate, Newcastle upon Tyne NE99 1YQ.
Solicitor Website http://www.watsonburton.com/
Solicitor Telephone +44 (0)1912 444 444
Stockbroker Name n/a
Stockbroker Address n/a
Stockbroker Website n/a
Stockbroker Telephone n/a